BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 32077355)

  • 1. Longitudinal clonal architecture of acute myeloid leukemia with
    Gallego Hernanz MP; Sorel N; Bouyer S; Desmier D; Chollet M; Maillard N; Brizard F; Moya N; Diaz JMT; Leleu X; Chomel JC
    Leuk Lymphoma; 2020 Jul; 61(7):1709-1713. PubMed ID: 32077355
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.
    Orsmark-Pietras C; Landberg N; Lorenz F; Uggla B; Höglund M; Lehmann S; Derolf Å; Deneberg S; Antunovic P; Cammenga J; Möllgård L; Wennström L; Lilljebjörn H; Rissler M; Fioretos T; Lazarevic VL
    Genes Chromosomes Cancer; 2021 Jun; 60(6):426-433. PubMed ID: 33433047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication.
    Kim MJ; Ahn S; Jeong SH; Jang JH; Han JH; Choi JR; Cho SR
    Ann Lab Med; 2016 May; 36(3):263-5. PubMed ID: 26915617
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloid leukemia, BCR-ABL1-positive, carrying NPM1 mutation - First case series from a single institution.
    Young PE; Kanagal-Shamanna R; Hu S; Tang G; Thakral B; Daver N; Issa GC; Medeiros LJ; Konoplev S
    Leuk Res; 2021 Dec; 111():106685. PubMed ID: 34438119
    [No Abstract]   [Full Text] [Related]  

  • 5. A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.
    Piedimonte M; Ottone T; Alfonso V; Ferrari A; Conte E; Divona M; Bianchi MP; Ricciardi MR; Mirabilii S; Licchetta R; Campagna A; Cicconi L; Galassi G; Pelliccia S; Leporace A; Lo Coco F; Tafuri A
    BMC Cancer; 2019 Jan; 19(1):50. PubMed ID: 30630459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.
    Tian X; Xu Y; Yin J; Tian H; Chen S; Wu D; Sun A
    Int J Hematol; 2014 Jul; 100(1):96-104. PubMed ID: 24859829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
    Bacher U; Haferlach T; Alpermann T; Zenger M; Hochhaus A; Beelen DW; Uppenkamp M; Rummel M; Kern W; Schnittger S; Haferlach C
    Br J Haematol; 2011 Mar; 152(6):713-20. PubMed ID: 21275954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden death of a SARS-CoV-2 patient with NPM1 + acute myeloid leukemia mimicking acute promyelocytic leukemia.
    Giammarco S; Chiusolo P; Sica S; Rossi M; Minnella G; Zini G
    Int J Lab Hematol; 2021 Jun; 43(3):341-342. PubMed ID: 33497032
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal Response in a Patient With CML Expressing
    Manzella L; Tirrò E; Vitale SR; Puma A; Consoli ML; Tambè L; Pennisi MS; DI Gregorio S; Romano C; Tomarchio C; DI Raimondo F; Stagno F
    In Vivo; 2020; 34(3):1481-1486. PubMed ID: 32354950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatment.
    Neuendorff NR; Schwarz M; Hemmati P; Türkmen S; Bommer C; Burmeister T; Dörken B; le Coutre P; Arnold R; Westermann J
    Acta Haematol; 2015; 133(2):237-41. PubMed ID: 25401297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
    Henry A; Bracquemart C; Naguib D; Chantepie S; Cheze S; Johnson-Ansah HA
    Br J Haematol; 2021 Nov; 195(3):469-471. PubMed ID: 34396510
    [No Abstract]   [Full Text] [Related]  

  • 12. BCR-ABL1-negative acute myeloid leukaemia relapsing as BCR-ABL1-positive disease.
    Bai S; Hu S
    Br J Haematol; 2017 Feb; 176(4):514. PubMed ID: 27982417
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion from nuclear bilobation to indentation in BCR/ABL1-positive acute myeloid leukemia lacking CD34 and HLA-DR expression.
    Yamamoto K; Yakushijin K; Sanada Y; Kawamoto S; Nakamachi Y; Kawano S; Matsuoka H; Minami H
    Ann Hematol; 2015 Jan; 94(1):177-9. PubMed ID: 24923453
    [No Abstract]   [Full Text] [Related]  

  • 14. BCR-ABL1 e6a2 transcript in chronic myeloid leukemia: biological features and molecular monitoring by droplet digital PCR.
    Zagaria A; Anelli L; Coccaro N; Tota G; Casieri P; Cellamare A; Impera L; Brunetti C; Minervini A; Minervini CF; Delia M; Cumbo C; Orsini P; Specchia G; Albano F
    Virchows Arch; 2015 Sep; 467(3):357-63. PubMed ID: 26149409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.
    Raman HS; Shanmugam V; Li J; Steensma DP; Kim AS; Luskin MR
    Leuk Lymphoma; 2021 Jul; 62(7):1790-1792. PubMed ID: 33586600
    [No Abstract]   [Full Text] [Related]  

  • 16. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
    Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A
    Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CML - Not only BCR-ABL1 matters.
    Rinke J; Hochhaus A; Ernst T
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101194. PubMed ID: 33038988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.
    Konoplev S; Yin CC; Kornblau SM; Kantarjian HM; Konopleva M; Andreeff M; Lu G; Zuo Z; Luthra R; Medeiros LJ; Bueso-Ramos CE
    Leuk Lymphoma; 2013 Jan; 54(1):138-44. PubMed ID: 22691121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of BCR/ABL1 p190 transcript and CEBPA double mutations in de novo acute myeloid leukemia.
    Zhang X; Guo X
    Leuk Lymphoma; 2019 Nov; 60(11):2844-2846. PubMed ID: 31050567
    [No Abstract]   [Full Text] [Related]  

  • 20. Acquired BCR-ABL1 fusion and IDH1 clonal evolution following BCL2 inhibitor treatment in refractory acute myeloid leukemia.
    Adrianzen-Herrera D; Jordan-Bruno X; Devitt KA; Conant JL; Gardner JA
    Leuk Res; 2021 Jan; 100():106494. PubMed ID: 33387682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.